Vepafestinib: a RET-selective inhibitor with enhanced CNS penetrance targets therapy-resistant mutants

  • Nat Cancer. 2023 Sep;4(9):1220-1221. doi: 10.1038/s43018-023-00631-x.
PMID: 37743367 DOI: 10.1038/s43018-023-00631-x
Products